focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.825
Bid: 1.80
Ask: 1.85
Change: 0.048 (2.46%)
Spread: 0.05 (2.778%)
Open: 1.95
High: 1.998
Low: 1.998
Prev. Close: 1.95
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

Mon, 20th Mar 2023 08:53

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil.

"It is not yet known exactly where more pain will emerge in the banking sector, but investors fear the problems are not yet over," said Susannah Streeter, head of money and markets at Hargreaves Lansdown.

The FTSE 100 index opened down 115.03 points, 1.6%, at 7,220.37. The FTSE 250 was down 405.08 points, or 2.2%, at 18,065.75, and the AIM All-Share was down 9.52 points, or 1.2%, at 794.51.

The Cboe UK 100 was down 1.5% at 722.97, the Cboe UK 250 was down 2.1% at 15,697.40, and the Cboe Small Companies was down 1.6% at 12,644.51.

UBS will take over its troubled Swiss rival Credit Suisse for USD3.25 billion following crunch talks on Sunday aimed at stopping the stricken bank from triggering a wider international banking crisis.

The Swiss government said the deal, involving Switzerland's biggest bank taking over the second-largest, was vital to prevent irreparable economic turmoil spreading throughout the country and beyond.

Michael Hewson, chief market analyst at CMC Markets, said: "Some have suggested that UBS putting such a low-ball number on its interest means that Credit Suisse could be in more trouble than perhaps regulators are letting on, and while that might be true, it could also be UBS management being extremely cautious."

Shares in UBS were 15% lower in Zurich on Monday morning. The bank has a market capitalisation of CHF53.17 billion. Shares in Credit Suisse plunged 63% for a market cap of just CHF2.78 billion, about USD2.99 billion.

The acquisition was welcomed in Washington, Brussels and London as one that would support financial stability.

The Bank of England has insisted the financial system in the UK remains "safe and sound", in an effort to calm fears after the emergency sale.

The pound was quoted at USD1.2170 at early on Monday in London, virtually unchanged compared to USD1.2168 at the London equities close on Friday.

In European equities on Monday, the CAC 40 in Paris was down 0.8%, while the DAX 40 in Frankfurt was down 1.0%.

France's central bank chief sought to distance European and French banks from the problems at Credit Suisse and banking woes in the US.

Credit Suisse and the banking volatility in the US "don't concern French and European banks", Francois Villeroy de Galhau, a member of the European Central Bank's governing council, told France Inter radio.

The euro stood at USD1.0636, lower from USD1.0665 late Friday. Against the yen, the dollar was trading at JPY130.69, down from JPY132.12.

Francesco Pesole at ING said he expects the yen to stay in demand for now amid the current risk-off market backdrop.

The US Federal Reserve and other major central banks are making a coordinated effort to improve banks' access to liquidity. The special drive will be launched on Monday by the Fed and the central banks of Canada, the UK, Japan, the EU and Switzerland.

The move comes after the US banking regulator struck a deal to sell most of the assets of the failed Signature Bank to another institution on Sunday.

Signature Bank was seized by the Federal Deposit Insurance Corp a week ago after it imploded in the wake of the collapse of Silicon Valley Bank earlier in March. The FDIC is seeking a similar deal to sell off parts of SVB, according to Bloomberg.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The next few hours of trading will give us a better picture on whether the crisis is contained."

In London, banking stocks were the worst performers in early morning trade. Barclays was down 7.4%, Standard Chartered down 8.0%, NatWest down 7.8%, and Lloyds down 4.6%. HSBC, which last week bought the UK arm of SVB, was 5.1% lower.

Conversely, mining stocks were some of Monday's top performers, with Fresnillo up 3.3% and Endeavour Mining up 6.2%.

Separately, the UK water services regulation authority Ofwat on Monday announced new powers that will enable it to stop the payment of dividends by water utilities if they would "risk the company's financial resilience". It said it would also take enforcement action against water companies that don't link dividend payments to performance.

Ofwat said the change will require company board to "take account of their performance" for customers and the environment when deciding to make dividend payments and will require companies to "maintain a higher level of overall financial health".

Water utilities were higher in early morning trade, with investors perhaps fearing worse from the regulator amid growing political pressure following the repeated release of sewage into UK rivers. United Utilities was up 1.2%, Severn Trent up 1.3%, and Pennon up 0.3%.

Elsewhere in the FTSE 100, Intertek was down 0.4%. The product testing, inspecting and certification firm announced the promotion of Colm Deasy to chief financial officer.

Deasy replaces Jonathan Timmis who has stepped down with immediate effect, with no reason provided by the company for his departure.

In the FTSE 250, FirstGroup fell 1.4% despite announcing it extended the current arrangements for its West Coast partnership rail contract with the UK Department for Transport.

The arrangements were set to expire on March 31 and have now been extended to October 15, "broadly" under the same terms and conditions, the public transport provider said.

The contract comprises of the operation of Avanti West Coast and the shadow operation of the HS2 programme.

On AIM, Genedrive jumped 8.1% after it announced that its MT-RNR1 ID kit is in process for roll out at two further hospital sites in the Greater Manchester.

Genedrive's MT-RNR1 ID kit is a commercial point-of-care genetic test that helps to avoid irreversible lifelong hearing loss in specific infants exposed to aminoglycosides antibiotics by detecting a gene variant that can cause deafness, allowing for alternative antibiotics to be prescribed.

In Asia on Monday, the Japanese Nikkei 225 index closed down 1.4%. In China, the Shanghai Composite closed down 0.5%, while the Hang Seng index in Hong Kong finished down 2.7%. The S&P/ASX 200 in Sydney lost 1.4%.

China's central bank left its interest rates unchanged. The People's Bank of China said it held its one-year loan prime rate - which serves as a benchmark for corporate loans - at 3.65%. The five-year rate also remained at 4.3%.

It was the seventh successive month that the PBoC left rates unchanged. The move had been anticipated by the market, according to FXStreet-cited consensus.

In the US on Friday, Wall Street ended lower, with the Dow Jones Industrial Average down 1.2%, the S&P 500 down 1.1% and the Nasdaq Composite down 0.7%.

Brent oil was quoted at USD70.26 a barrel early in London on Monday, down from USD73.43 late Friday. Gold was quoted at USD2,004.05 an ounce, sharply higher against USD1,957.76.

Naeem Aslam, chief investment officer at Zaye Capital Markets, said the yellow metal remains in demand because investors believe that banks are not out of the woods yet.

"Traders always prefer safe haven in a situation like this as the contagion risk is always very high," Aslam said.

Still to come in Monday's economic calendar, there is a US retail trade report at 1400 GMT.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
9 Feb 2023 10:36

Genedrive hearing loss test recommended by UK health department body

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence has preliminarily recommended its antibiotic hearing loss test, the MT-RNR1 ID kit.

Read more
9 Feb 2023 09:13

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings.

Read more
3 Feb 2023 10:26

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
29 Dec 2022 21:58

IN BRIEF: Genedrive shareholders vote down pre-emption rights power

Genedrive PLC - Manchester-based molecular diagnostics company - Reports that 21% of its shareholders voted against resolution 3 for the reappointment Tom Lindsay as a director at its annual general meeting on Thursday. 32% of its shareholders voted against resolution 5 for the reappointment of David Budd as a director, and 25% of shareholders voted against resolution 6 for the reappointment of Ian Gilham as a director. Adds that 25% of shareholders voted against resolution 10, to authorise the directors to allot equity securities in the capital.

Read more
22 Dec 2022 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 December 
Plexus Holdings PLCAGM
Wildcat Petroleum PLCAGM
Monday 26 December 
no events scheduled 
Tuesday 27 December 
Zambeef Products PLCAGM
Wednesday 28 December 
Evrima PLCAGM
Greencare Capital PLCGM re proposed name change
Lift Global Ventures PLCGM re proposed expansion within the energy sector
Thursday 29 December 
Amte Power PLCAGM
ADVFN PLCAGM
Genedrive PLCAGM
Hotel Chocolat Group PLCAGM
Lekoil LtdEGM re proposed settlement and name change
Online Blockchain PLCAGM
PetroNeft Resources PLCAGM
SkinBioTherapeutics PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Nov 2022 12:19

Genedrive shares slump as loss widens on lack of Covid-19 revenue

(Alliance News) - Genedrive PLC on Monday reported a substantially widened pretax loss as revenue slumped due to a lack of Covid-19 revenue.

Read more
21 Nov 2022 11:15

AIM WINNERS & LOSERS: Real Good Food secures turnaround funds

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
14 Nov 2022 14:32

UK earnings, trading statements calendar - next 7 days

Tuesday 15 November 
AdEPT Technology Group PLCHalf Year Results
BAE Systems PLCTrading Statement
Gear4Music PLCHalf Year Results
Imperial Brands PLCFull Year Results
Land Securities Group PLCHalf Year Results
Melrose Industries PLCTrading Statement
Ninety One PLC and LtdHalf Year Results
R&Q Insurance Holdings LtdQ1 Results
Speedy Hire PLCHalf Year Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wincanton PLCHalf Year Results
Workspace Group PLCHalf Year Results
Wednesday 16 November 
Aristocrat Leisure LtdFull Year Results
Bridgepoint Group PLCTrading Statement
British Land Co PLCHalf Year Results
Castings PLCHalf Year Results
CMC Markets PLCHalf Year Results
Enteq Technologies PLCHalf Year Results
Experian PLCHalf Year Results
Hill & Smith PLCTrading Statement
Mediclinic International PLCHalf Year Results
Nightcap PLCFull Year Results
Premier Foods PLCHalf Year Results
Renold PLCHalf Year Results
Sage Group PLCFull Year Results
Schroder Global Real Estate SecuritiesHalf Year Results
Schroder Real Estate Investment Trust LtdHalf Year Results
SSE PLCHalf Year Results
Thursday 17 November 
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
Fuller, Smith & Turner PLCHalf Year Results
Grainger PLCFull Year Results
Great Portland Estates PLCHalf Year Results
Halma PLCHalf Year Results
Integrated Diagnostics Holdings PLCQ3 Results
Intermediate Capital Group PLCHalf Year Results
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Keller Group PLCTrading Statement
Kier Group PLCTrading Statement
Mitie Group PLCHalf Year Results
Pershing Square Holdings LtdQ3 Results
Redcentric PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tyman PLCTrading Statement
Virgin Money UK PLCFull Year Results
Zytronic PLCFull Year Results
Friday 18 November 
Bank of Cyprus Holdings PLCQ3 Results
Liontrust Asset Management PLCHalf Year Results
Monday 21 November 
Big Yellow Group PLCHalf Year Results
Compass Group PLCFull Year Results
Dialight PLCTrading Statement
Diploma PLCFull Year Results
Equipmake Holdings PLCFull Year Results
Genedrive PLCFull Year Results
Molten Ventures PLCHalf Year Results
MTI Wireless Edge LtdQ3 Results
NextEnergy Solar Fund LtdHalf Year Results
Polar Capital Holdings PLCHalf Year Results
Sirius Real Estate LtdHalf Year Results
SysGroup PLCHalf Year Results
Virgin Money UK PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
5 Oct 2022 11:40

Genedrive shares surge as pre-submission for MT-RNR1 filed to FDA

(Alliance News) - Genedrive PLC on Wednesday said it has started engagement with the US Food & Drug Administration to progress the approval of its MT-RNR1 product range into the US.

Read more
5 Oct 2022 11:03

Genedrive engages with US FDA over infant test

(Sharecast News) - Near-patient molecular diagnostics company Genedrive has started engaging with the US Food and Drug Administration (FDA), it announced on Wednesday, to progress the regulatory approval of its 'MT-RNR1 ID Kit' into the United States.

Read more
26 Sep 2022 14:24

Genedrive says its "world first" test has been accelerated by NICE

(Alliance News) - Genedrive PLC on Monday said that its Genedrive MT-RNR1 test has been accelerated by the UK's National Institute for Health & Clinical Excellence.

Read more
26 Sep 2022 14:10

Genedrive test to go through new, faster NICE process

(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.

Read more
22 Aug 2022 11:48

Genedrive's CYP2C19 ID Kit included in UK's NICE assessment

(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment.

Read more
22 Aug 2022 10:39

Another Genedrive test to be assessed by NICE

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of CYP2C19 genotype testing for clopidogrel treatment, via a new NICE diagnostics assessment programme (DAP).

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.